VectorY Therapeutics
在场
高管
查看带有其 12 名主要高管的组织结构图
VectorY Therapeutics 搜索最多的简介
- Sander van Deventer, Co-Founder and Chief Executive Officer
- Arno de Wilde, Director
- Marco Boorsma, Member of the Supervisory Board
高管在VectorY Therapeutics变化
- Khurem Farooq已作为Director加入公司 (新闻发布的2024一月19号).
创建提醒
跟踪 VectorY Therapeutics 的高管变动
生物技术
VectorY Therapeutics 拥有 2,284 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
- WindRose Health Investors has announced the acquisition of SubjectWell (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
VectorY Therapeutics 的最新新闻稿
- VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases — VectoryTx
- Press releases and news — VectoryTx
- VectorY to Present at the ASGCT Annual Meeting in May 2023 — VectoryTx
- VectorY to Present at the Bio€quity Europe Conference in May — VectoryTx
- VectorY to Participate in Key Sector Conferences in April 2023 — VectoryTx
- VectorY Appoints Michael Wyzga as CFO and adds Jean Franchi to its Board of Directors — VectoryTx
- VectorY and Annogen Announce Research Collaboration — VectoryTx
- View more press releases Close
通过电子邮件
